Whitepaper:
Turning Innovation into Predictable Cash Flow
How CFOs use public funding programmes as a strategic financial tool
What you can expect from this white paper
Companies spending €5 million a year on R&D can secure €1.05 million to €1.4 million in annual cash inflow through the research tax credit, plus a one-off retrospective benefit of up to €5.6 million. Most never claim it. Not because they are ineligible. Because three structural flaws block it: funding treated as a project rather than a process, finance and R&D working in silos, and liquidity effects left out of financial planning.
That is a governance deficit, and it shows up directly in cash flow, margins and audit assurance. This white paper is for CFOs and finance leaders who treat funding as a financial instrument, not an application. It explains how a group-wide process changes the profit and loss account, cash flow and equity ratio.
The Reality of Being a CFO & the Typical Pitfalls
- How margin pressure, the need to invest and compliance hurdles will shape day-to-day finance in 2026
- Why most funding approaches fail due to the typical silos between Finance, Tax and R&D
- How to shift the focus from an ad hoc project search to a predictable financial process
Figures that matter: the real liquidity leverage
- How to use the research allowance to directly recoup up to 35 per cent of your eligible R&D staff costs
- How to capitalise on unused one-off benefits of up to 5.6 million euros through the four-year retroactive effect
- Case study: How a medium-sized engineering firm established an annual cash inflow of 1.7 million euros as the norm
The 5-step approach to corporate security
- How to clearly define the scope of your R&D activities in a methodical manner and eliminate compliance risks
- How to establish standardised processes that have a direct impact on EBIT, cash flow and the equity ratio
- The quickest and most audit-proof way to your first strategic R&D funding assessment
Download the white paper now
Download our white paper now. It shows you how to systematically unlock the potential for annual savings running into millions on your R&D costs, why the typical silos between Finance and R&D jeopardise your funding, and how a group-wide process can sustainably strengthen your profit and loss account, liquidity and audit assurance.